Gail K. Naughton's Insider Trades & SAST Disclosures

Gail K. Naughton's most recent trade in TherapeuticsMD Inc was a trade of 8,500 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 8,500 8,500 (0%) 0% 0 Common Stock
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 8,500 0 - - Restricted Stock Units
TherapeuticsMD Inc
Gail K. Naughton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 8,500 8,500 - - Restricted Stock Unit
TherapeuticsMD Inc
Gail K. Naughton Director Sale of securities on an exchange or to another person at price $ 5.26 per share. 07 Dec 2022 3,922 0 (0%) 0% 5.3 20,635 Common Stock
TherapeuticsMD Inc
Gail K. Naughton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Sep 2022 5,000 5,000 - - Restricted Stock Units
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2022 1,984 0 - - Restricted Stock Units
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2022 1,984 3,922 (0%) 0% - Common Stock
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 96,864 0 - - Restricted Stock Units
TherapeuticsMD Inc
Gail K. Naughton Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 96,864 96,864 (0%) 0% - Common Stock
TherapeuticsMD Inc
Gail K. Naughton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2021 99,174 99,174 - - Restricted Stock Units
Histogen Inc
Gail K. Naughton See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2021 95,000 95,000 - - Stock Option (right to buy)
TherapeuticsMD Inc
Gail K. Naughton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 96,864 96,864 - - Restricted Stock Units
Histogen Inc
Gail K. Naughton See Remarks Other type of transaction at price $ 0.00 per share. 26 May 2020 426,526 426,526 - 0 Common Stock
Histogen Inc
Gail K. Naughton See Remarks Other type of transaction at price $ 0.00 per share. 26 May 2020 380,063 380,063 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades